Precipio, Inc.
PRPO
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary andā¦ read more
Healthcare
Diagnostics & Research
9 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$24.69
Price+3.31%
$0.79
1Y
Price
Market Cap
$44.039m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-15.4%
EBITDA Margin-22.9%
Net Profit Margin+0.2%
Free Cash Flow Margin-15.4%
EBITDA Margin-22.9%
Net Profit Margin+0.2%
Free Cash Flow MarginRevenue
$26.094m
+8.5%
1y CAGR+21.4%
3y CAGR+31.4%
5y CAGREarnings
-$922k
-154.0%
1y CAGR-11.9%
3y CAGR+4.1%
5y CAGREPS
-$0.48
-108.7%
1y CAGR+6.2%
3y CAGR+19.1%
5y CAGRBook Value
$14.167m
$20.803m
Assets$6.636m
Liabilities$3.492m
DebtDebt to Assets
16.8%
4.1x
Debt to EBITDAFree Cash Flow
$555k
+54.6%
1y CAGR+75.6%
3y CAGR+70.2%
5y CAGRNo items found.
Press Releases
Statements and updates from the company